Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas

被引:69
|
作者
Yoon, Jiyoung [1 ]
Suh, Young Joo [1 ]
Han, Kyunghwa [1 ]
Cho, Hyoun [1 ]
Lee, Hye-Jeong [1 ]
Hur, Jin [1 ]
Choi, Byoung Wook [1 ]
机构
[1] Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea
关键词
Computed tomography; immunotherapy; lung adenocarcinoma; programmed death ligand 1; radiomics; FACTOR RECEPTOR MUTATION; DEATH LIGAND 1; EGFR MUTATION; INTERNATIONAL ASSOCIATION; COMPUTED-TOMOGRAPHY; TEXTURE ANALYSIS; STAGE-I; CANCER; CLASSIFICATION; FEATURES;
D O I
10.1111/1759-7714.13352
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We aimed to assess if quantitative radiomic features can predict programmed death ligand 1 (PD-L1) expression in advanced stage lung adenocarcinoma. Methods This retrospective study included 153 patients who had advanced stage (>IIIA by TNM classification) lung adenocarcinoma with pretreatment thin section computed tomography (CT) images and PD-L1 expression test results in their pathology reports. Clinicopathological data were collected from electronic medical records. Visual analysis and radiomic feature extraction of the tumor from pretreatment CT were performed. We constructed two models for multivariate logistic regression analysis (one based on clinical variables, and the other based on a combination of clinical variables and radiomic features), and compared c-statistics of the receiver operating characteristic curves of each model to identify the model with the higher predictability. Results Among 153 patients, 53 patients were classified as PD-L1 positive and 100 patients as PD-L1 negative. There was no significant difference in clinical characteristics or imaging findings on visual analysis between the two groups (P > 0.05 for all). Rad-score by radiomic analysis was higher in the PD-L1 positive group than in the PD-L1 negative group with a statistical significance (-0.378 +/- 1.537 vs. -1.171 +/- 0.822, P = 0.0008). A prediction model that uses clinical variables and CT radiomic features showed higher performance compared to a prediction model that uses clinical variables only (c-statistic = 0.646 vs. 0.550, P = 0.0299). Conclusions Quantitative CT radiomic features can predict PD-L1 expression in advanced stage lung adenocarcinoma. A prediction model composed of clinical variables and CT radiomic features may facilitate noninvasive assessment of PD-L1 expression. Key points Significant findings of the study Quantitative CT radiomic features can help predict PD-L1 expression, whereas none of the qualitative imaging findings is associated with PD-L1 positivity. What this study adds A prediction model composed of clinical variables and CT radiomic features may facilitate noninvasive assessment of PD-L1 expression.
引用
收藏
页码:993 / 1004
页数:12
相关论文
共 50 条
  • [41] Correlation of CT parameters and PD-L1 expression status in gastric cancer
    Min Xu
    Tiezhu Ren
    Juan Deng
    Jingjing Yang
    Ting Lu
    Huaze Xi
    Long Yuan
    Wenjuan Zhang
    Junlin Zhou
    Abdominal Radiology, 2024, 49 : 1320 - 1329
  • [42] What does radiomics do in PD-L1 blockade therapy of NSCLC patients?
    Cui, Ruichen
    Yang, Zhenyu
    Liu, Lunxu
    THORACIC CANCER, 2022, 13 (19) : 2669 - 2680
  • [43] PD-L1 expression according to the EGFR status in primary lung adenocarcinoma
    Takada, Kazuki
    Toyokawa, Gouji
    Tagawa, Tetsuzo
    Kohashi, Kenichi
    Shimokawa, Mototsugu
    Akamine, Takaki
    Takamori, Shinkichi
    Hirai, Fumihiko
    Shoji, Fumihiro
    Okamoto, Tatsuro
    Oda, Yoshinao
    Maehara, Yoshihiko
    LUNG CANCER, 2018, 116 : 1 - 6
  • [44] PD-L1 Expression in Lung Adenocarcinomas Correlates with KRAS Mutations and Th1/Cytotoxic T Lymphocyte Microenvironment
    Huynh, Tiffany
    Morales-Oyarvide, Vicente
    Uruga, Hironori
    Bozkurtlar, Emine
    Gainor, Justin F.
    Hata, Aaron
    Mark, Eugene
    Lanuti, Michael
    Engelman, Jeffrey A.
    Mino-Kenudson, Mari
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S198 - S198
  • [45] The value of CT-based radiomics in early assessment of chemotherapeutic effect in patients with advanced lung adenocarcinoma: a preliminary study
    Lin, Xi
    Wang, Huaming
    Chen, Jiayou
    Lu, Tao
    Zheng, Dechun
    Chen, Ying
    Chen, Yunbin
    ACTA RADIOLOGICA, 2023, 64 (02) : 524 - 532
  • [46] A radiomics nomogram prediction for survival of patients with "driver gene-negative" lung adenocarcinomas (LUAD)
    Guo, Qi-Kun
    Yang, Hao-Shuai
    Shan, Shi-Chao
    Chang, Dan-Dan
    Qiu, Li-Jie
    Luo, Hong-He
    Li, He-Ping
    Ke, Zun-Fu
    Zhu, Ying
    RADIOLOGIA MEDICA, 2023, 128 (06): : 714 - 725
  • [47] Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases
    Uruga, Hironori
    Bozkurtlar, Emine
    Huynh, Tiffany
    Muzikansky, Alona
    Hata, Aaron
    Gainor, Justin F.
    Mark, Eugene
    Engelman, Jeffrey A.
    Lanuti, Michael
    Mino-Kenudson, Mari
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S266 - S266
  • [48] Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancer
    Aviles-Salas, Alejandro
    Flores-Estrada, Diana
    Lara-Mejia, Luis
    Catalan, Rodrigo
    Cruz-Rico, Graciela
    Orozco-Morales, Mario
    Heredia, David
    Bolano-Guerra, Laura
    Soberanis-Pina, Pamela Denisse
    Varela-Santoyo, Edgar
    Cardona, Andres F.
    Arrieta, Oscar
    THORACIC CANCER, 2022, 13 (23) : 3362 - 3373
  • [49] Assessing PD-L1 Expression Level via Preoperative MRI in HCC Based on Integrating Deep Learning and Radiomics Features
    Tian, Yuchi
    Komolafe, Temitope Emmanuel
    Zheng, Jian
    Zhou, Guofeng
    Chen, Tao
    Zhou, Bo
    Yang, Xiaodong
    DIAGNOSTICS, 2021, 11 (10)
  • [50] The mechanism of ABL1 upregulating the expression of PD-L1 and the therapeutic effect of PD-L1 and STAT3 inhibitors in lung adenocarcinoma
    Tang, Dongfang
    Jiang, Haoyao
    Li, Zhigang
    Gao, Wen
    Sun, Yifeng
    NEOPLASMA, 2021, 68 (03) : 472 - 481